We are Cobaltous Sulphate CAS:10026-24-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Other name:
Cobaltous Sulphate
CAS No.: 10026-24-1
CoSO4·7H2O
Molecular Weight: 281.1
Characters: Brownish yellow light red crystal. easily soluble in water and methanol.
Specifications:
Cobaltous Sulphate | Reagent grade A.R. | Reagent grade C.P. | Technical grade |
Item | Spec. | Spec. | Spec. |
Assay % | ≥99.5 | ≥98.5 | ≥98.0 |
Water insoluble% | ≤0.005 | ≤0.01 | ≤0.02 |
Chlorides(Cl) % | ≤0.002 | ≤0.005 | ≤0.02 |
Total N % | ≤0.05 | ≤0.05 | — |
Mn% | ≤0.005 | ≤0.02 | ≤0.02 |
Fe% | ≤0.001 | ≤0.005 | ≤0.01 |
Ni% | ≤0.01 | ≤0.1 | ≤0.1 |
Zn% | ≤0.005 | ≤0.02 | ≤0.02 |
Na% | ≤0.01 | ≤0.05 | ≤0.05 |
Ca% | ≤0.005 | ≤0.025 | ≤0.05 |
Cu% | ≤0.001 | ≤0.005 | ≤0.01 |
Product Usage: Used in the manufacture of electronic materials using cobalt oxide and metal cobalt as alloy; also used in the manufacture of barometer, gravimeter and sympathetic ink etc.
Packaging: 25kg cardboard drum, lined with double-layer plastic bag
Storage Precautions: Stored in cool, draughty and dry place at room temperature.
Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.(3R)-piperidin-3-amine,dihydrochloride Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.2',3',5'-Tri-O-acetyl-2-fluoroadenosine CAS:15811-32-2 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.4-Bromo-3-chlorobenzotrifluoride CAS:402-04-0 Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.
Product Name | |
---|---|
Blonanserin Cas:NO:132810-10-7 | View Details |
1-methoxy-2-propanol Cas:107-98-2 (1) | View Details |
Norfenefrine Hydrochloride Cas:15308-34-6 | View Details |